J Thomas Pento

Title: J Thomas Pento: Innovator in Cancer Treatment

Introduction

J Thomas Pento is a notable inventor based in Norman, Oklahoma. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. His work focuses on developing methods to prevent cancer metastasis, which is a critical area of study in oncology.

Latest Patents

J Thomas Pento holds a patent for "Keratinocyte growth factor receptor—tyrosine specific inhibitors for the prevention of cancer metastasis." This patent describes compounds and methods for treating, inhibiting, or delaying the onset of cancer by administering a therapeutically effective amount of a keratinocyte growth factor receptor tyrosine kinase (KGFR TK) inhibitor. The invention aims to provide effective treatment options for subjects in need of such intervention.

Career Highlights

Throughout his career, J Thomas Pento has worked with prestigious institutions such as The Ohio State University and the University of Oklahoma. His research has contributed to advancements in cancer treatment methodologies, showcasing his dedication to improving patient outcomes.

Collaborations

Some of his notable coworkers include Pui-Kai Li and Robert Brueggemeier. Their collaborative efforts have furthered the understanding and development of cancer treatment strategies.

Conclusion

J Thomas Pento's innovative work in cancer treatment exemplifies the impact of dedicated research and invention in the medical field. His contributions continue to pave the way for advancements in oncology and patient care.